| Uti Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | - | ||||
| Rating | ||||||
| Growth Option | ||||||
| NAV | (R) | % | (D) | % | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | |||||
| Direct | ||||||
| Nifty Pharma TRI | 19.97% | 20.53% | 14.18% | 19.98% | 9.31% | |
| SIP (XIRR) | Regular | |||||
| Direct | ||||||
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| 1.16 | 0.61 | 1.02 | 3.84% | 0.22 | ||
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| 16.48% | -19.01% | -15.36% | 0.91 | 11.67% | ||
| Fund AUM | As on: 30/12/2025 | 1118 Cr | ||||
No data available
NAV Date:
no dataReview Date:
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| Standard Deviation | 16.48 |
15.95
|
14.65 | 16.87 | 5 | 8 | Average | |
| Semi Deviation | 11.67 |
11.39
|
10.68 | 12.13 | 6 | 8 | Average | |
| Max Drawdown % | -15.36 |
-14.76
|
-16.36 | -12.33 | 5 | 8 | Average | |
| VaR 1 Y % | -19.01 |
-18.95
|
-23.32 | -15.67 | 5 | 8 | Average | |
| Average Drawdown % | 4.94 |
5.47
|
3.66 | 6.79 | 6 | 8 | Average | |
| Sharpe Ratio | 1.16 |
1.04
|
0.87 | 1.20 | 2 | 8 | Very Good | |
| Sterling Ratio | 1.02 |
0.94
|
0.81 | 1.09 | 2 | 8 | Very Good | |
| Sortino Ratio | 0.61 |
0.54
|
0.44 | 0.63 | 2 | 8 | Very Good | |
| Jensen Alpha % | 3.84 |
1.66
|
-0.46 | 3.84 | 1 | 8 | Very Good | |
| Treynor Ratio | 0.22 |
0.20
|
0.16 | 0.23 | 2 | 8 | Very Good | |
| Modigliani Square Measure % | 19.06 |
17.20
|
14.35 | 19.86 | 2 | 8 | Very Good | |
| Alpha % | 2.85 |
0.06
|
-1.73 | 3.02 | 2 | 8 | Very Good |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| Standard Deviation | 16.48 | 15.95 | 14.65 | 16.87 | 5 | 8 | Average | |
| Semi Deviation | 11.67 | 11.39 | 10.68 | 12.13 | 6 | 8 | Average | |
| Max Drawdown % | -15.36 | -14.76 | -16.36 | -12.33 | 5 | 8 | Average | |
| VaR 1 Y % | -19.01 | -18.95 | -23.32 | -15.67 | 5 | 8 | Average | |
| Average Drawdown % | 4.94 | 5.47 | 3.66 | 6.79 | 6 | 8 | Average | |
| Sharpe Ratio | 1.16 | 1.04 | 0.87 | 1.20 | 2 | 8 | Very Good | |
| Sterling Ratio | 1.02 | 0.94 | 0.81 | 1.09 | 2 | 8 | Very Good | |
| Sortino Ratio | 0.61 | 0.54 | 0.44 | 0.63 | 2 | 8 | Very Good | |
| Jensen Alpha % | 3.84 | 1.66 | -0.46 | 3.84 | 1 | 8 | Very Good | |
| Treynor Ratio | 0.22 | 0.20 | 0.16 | 0.23 | 2 | 8 | Very Good | |
| Modigliani Square Measure % | 19.06 | 17.20 | 14.35 | 19.86 | 2 | 8 | Very Good | |
| Alpha % | 2.85 | 0.06 | -1.73 | 3.02 | 2 | 8 | Very Good |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Uti Healthcare Fund NAV Regular Growth | Uti Healthcare Fund NAV Direct Growth |
|---|---|---|
| 18-08-2026 | 340.93 | 388.4546 |
| 17-08-2026 | 340.5796 | 388.0452 |
| 14-08-2026 | 341.2516 | 388.7807 |
| 13-08-2026 | 341.3732 | 388.909 |
| 12-08-2026 | 340.7578 | 388.1979 |
| 11-08-2026 | 343.0751 | 390.8277 |
| 10-08-2026 | 339.8774 | 387.1749 |
| 07-08-2026 | 338.6528 | 385.7499 |
| 06-08-2026 | 337.9196 | 384.9048 |
| 05-08-2026 | 337.6695 | 384.6099 |
| 04-08-2026 | 336.661 | 383.4513 |
| 03-08-2026 | 336.7684 | 383.5637 |
| 31-07-2026 | 334.5099 | 380.9617 |
| 30-07-2026 | 334.056 | 380.4349 |
| 29-07-2026 | 335.2331 | 381.7656 |
| 28-07-2026 | 330.6129 | 376.4942 |
| 27-07-2026 | 331.6426 | 377.6571 |
| 24-07-2026 | 326.0473 | 371.2567 |
| 23-07-2026 | 326.7149 | 372.0071 |
| 22-07-2026 | 328.7755 | 374.3437 |
| 21-07-2026 | 334.0518 | 380.3415 |
| 20-07-2026 | 333.5856 | 379.8008 |
| Fund Launch Date: 27/May/1999 |
| Fund Category: Pharma Fund |
| Investment Objective: The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equities and equity related securities of companies/ institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved. |
| Fund Description: An open ended equity scheme investing in the Healthcare Services Sector |
| Fund Benchmark: S&P BSE Healthcare |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.